| Nitric oxide and redox mechanisms in the immune response DA Wink, HB Hines, RYS Cheng, CH Switzer, W Flores-Santana, ... Journal of leukocyte biology 89 (6), 873-891, 2011 | 847 | 2011 |
| Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy CH Switzer, RYS Cheng, TM Vitek, DJ Christensen, DA Wink, MP Vitek Oncogene 30 (22), 2504-2513, 2011 | 199 | 2011 |
| Persistent Hypomethylation in the Promoter of Nucleosomal Binding Protein 1 (Nsbp1) Correlates with Overexpression of Nsbp1 in Mouse Uteri Neonatally … WY Tang, R Newbold, K Mardilovich, W Jefferson, RYS Cheng, ... Endocrinology 149 (12), 5922-5931, 2008 | 194 | 2008 |
| Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression JL Heinecke, LA Ridnour, RYS Cheng, CH Switzer, MM Lizardo, ... Proceedings of the National Academy of Sciences 111 (17), 6323-6328, 2014 | 190 | 2014 |
| Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors JM Weiss, LC Davies, M Karwan, L Ileva, MK Ozaki, RYS Cheng, ... The Journal of clinical investigation 128 (9), 3794-3805, 2018 | 181 | 2018 |
| Molecular pathways: toll-like receptors in the tumor microenvironment—poor prognosis or new therapeutic opportunity LA Ridnour, RYS Cheng, CH Switzer, JL Heinecke, S Ambs, S Glynn, ... Clinical Cancer Research 19 (6), 1340-1346, 2013 | 168 | 2013 |
| Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism V Somasundaram, D Basudhar, G Bharadwaj, JH No, LA Ridnour, ... Antioxidants & Redox Signaling 30 (8), 1124-1143, 2019 | 145 | 2019 |
| S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer CH Switzer, SA Glynn, RYS Cheng, LA Ridnour, JE Green, S Ambs, ... Molecular Cancer Research 10 (9), 1203-1215, 2012 | 137 | 2012 |
| Signaling and stress: The redox landscape in NOS2 biology DD Thomas, JL Heinecke, LA Ridnour, RY Cheng, AH Kesarwala, ... Free Radical Biology and Medicine 87, 204-225, 2015 | 135 | 2015 |
| The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems W Flores-Santana, DJ Salmon, S Donzelli, CH Switzer, D Basudhar, ... Antioxidants & redox signaling 14 (9), 1659-1674, 2011 | 107 | 2011 |
| Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer D Basudhar, SA Glynn, M Greer, V Somasundaram, JH No, DA Scheiblin, ... Proceedings of the National Academy of Sciences 114 (49), 13030-13035, 2017 | 97 | 2017 |
| Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer CH Switzer, RYS Cheng, LA Ridnour, SA Glynn, S Ambs, DA Wink Breast Cancer Research 14, 1-13, 2012 | 95 | 2012 |
| Epigenetic and gene expression changes related to transgenerational carcinogenesis RYS Cheng, T Hockman, E Crawford, LM Anderson, YH Shiao Molecular Carcinogenesis: Published in cooperation with the University of …, 2004 | 95 | 2004 |
| Inducible nitric oxide synthase in the carcinogenesis of gastrointestinal cancers GA de Oliveira, RYS Cheng, LA Ridnour, D Basudhar, V Somasundaram, ... Antioxidants & redox signaling 26 (18), 1059-1077, 2017 | 92 | 2017 |
| Biological signaling by small inorganic molecules D Basudhar, LA Ridnour, R Cheng, AH Kesarwala, J Heinecke, DA Wink Coordination chemistry reviews 306, 708-723, 2016 | 89 | 2016 |
| Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation LA Ridnour, KM Barasch, AN Windhausen, TH Dorsey, MM Lizardo, ... Public Library of Science 7 (9), e44081, 2012 | 84 | 2012 |
| Nitric oxide synthase-2-derived nitric oxide drives multiple pathways of breast cancer progression D Basudhar, V Somasundaram, GA de Oliveira, A Kesarwala, ... Antioxidants & redox signaling 26 (18), 1044-1058, 2017 | 82 | 2017 |
| Synthesis and chemical and biological comparison of nitroxyl-and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives D Basudhar, G Bharadwaj, RY Cheng, S Jain, S Shi, JL Heinecke, ... Journal of medicinal chemistry 56 (20), 7804-7820, 2013 | 74 | 2013 |
| Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer CH Switzer, SA Glynn, LA Ridnour, RYS Cheng, MP Vitek, S Ambs, ... Trends in pharmacological sciences 32 (11), 644-651, 2011 | 74 | 2011 |
| Nitric oxide‐mediated regulation of‐amyloid clearance via alterations of MMP‐9/TIMP‐1 LA Ridnour, S Dhanapal, M Hoos, J Wilson, J Lee, RYS Cheng, ... Journal of neurochemistry 123 (5), 736-749, 2012 | 71 | 2012 |
David WinkSenior Investigator National Cancer InstituteBestätigte E-Mail-Adresse bei mail.nih.gov
